Help
Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Insights: Gastroenterology
The treatment for localized advance gastrointestinal stromal tumor (GIST) is far from ideal. Up to 50% of patient developed post-operative recurrence and died within 5 years. Recently, imatinib was found to significantly improve recurrence-free survival in post-operative patients. The role of adjuvant therapy in high risk GIST patients is discussed.
PDF (412.86 KB PDF FORMAT)
RIS citation (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)
BibTex citation (BIBDESK, LATEX)
STUMBLE UPON 
CITEULIKE 
DIGG 
FACEBOOK 
MENDELEY 
LINKED IN 
TWITTER
I had a really positive experience publishing in Clinical Medicine Insights: Gastroenterology. The submission process is easy and friendly. The review process is very accurate with a considerable quantity of reviewers who give helpful and reasonable suggestions. The staff are professional and gives prompt email responses. I recommend colleagues to consider publishing with Libertas Academica.
Facebook Google+ Twitter
Pinterest Tumblr YouTube